ABSTRACT ⌬
-THC in sesame oil, has been used clinically to stimulate appetite and reduce nausea in patients undergoing chemotherapy for cancer and AIDS (Plasse et al., 1991) . ⌬ 9 -THC also appears to have other useful clinical attributes including analgesic, antiglaucoma, and antiepileptic properties (Howlett, 1995; Adams and Martin, 1996) .
The effects of ⌬ 9 -THC are mediated by cannabinoid receptors that are distributed throughout the central nervous system (Herkenham et al., 1990; Tsou et al., 1998) and are present at high density on the presynaptic terminals of glutamatergic synapses (Twitchell et al., 1997) . Cannabinoid receptors are members of the G-protein-coupled receptor family (Matsuda et al., 1990) and act via inhibitory G proteins to activate K ϩ channels Henry and Chavkin, 1995; Mackie et al., 1995) and inhibit Ca ϩϩ channels (Mackie and Hille, 1992; Twitchell et al., 1997; Shen and Thayer, 1998) . The activation of these receptors by cannabimimetic drugs attenuates glutamatergic neurotransmission by acting presynaptically to inhibit the release of glutamate .
The cannabinoid neuromodulatory system exhibits an extensive pharmacology with several endogenous lipids proposed as ligands (Devane et al., 1992) as well as a number of synthetic cannabinoid (Johnson and Melvin, 1986 ) and aminoalkylindole (D'Ambra et al., 1992) derivatives that vary in potency, efficacy and stereoselectivity. In radioligand binding assays, compounds with affinities that range from subnano-molar to micromolar have been described (Devane et al., 1988; Herkenham et al., 1990) . Some of the putative endogenous ligands as well as some of the cannabinoid derivatives behave as partial agonists in receptor mediated inhibition of Ca ϩϩ channels, G protein activation and synaptic transmission (Mackie et al., 1993; Pan et al., 1996; Sim et al., 1996b; Burkey et al., 1997a) . In some behavioral assays, the maximal effects of ⌬ 9 -THC were less than other cannabimimetic drugs, suggesting that it acted as a partial agonist (Compton et al., 1992) . The stereoisomers of the aminoalkylindole Win55212-2 differ by over 100-fold in activity for inhibition of electrically stimulated mouse vas deferens (D'Ambra et al., 1992) .
The effects of ⌬ 9 -THC on excitatory synaptic transmission have not been described. In this report, we show that ⌬ 9 -THC is a potent inhibitor of glutamatergic synaptic transmission, although it exhibits partial inhibition at maximal concentrations. The ability of this drug to reduce, but not block, excitatory neurotransmission explains some of its behavioral effects.
Materials and Methods
Materials were obtained from the following companies: Win55212-2 and 6-cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX), RBI, Natick, MA; N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide (SR141716) , Sanofi Recherche, Montpellier Cedex, France; ⌬ 9 -THC and all other reagents, Sigma Chemical Co., St. Louis, MO.
Rat hippocampal neurons were grown in primary culture as previously described (Wang et al., 1994) with minor modifications. Neurons dissociated from hippocampi of embryonic day 17 rats were plated as a droplet onto glass coverslips at an approximate density of 2.2 ϫ 10 4 cells/cm 2 (5 ϫ 10 4 cells/well). Cultures were grown without mitotic inhibitors for a minimum of 12 days before use.
Whole-cell currents were recorded with an Axopatch 200A patchclamp amplifier and the BASIC-FASTLAB interface system (Indec Systems, Sunnyvale, CA). For recording EPSCs, pipettes (3-5 M⍀ resistance) were pulled from borosilicate glass (Narashige USA, Inc. Greenvale, NY) and filled with a solution containing: K-gluconate, 130 mM; KCl, 10 mM; NaCl, 10 mM; 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid, 10 mM; HEPES, 10 mM; Glucose, 10 mM; MgATP, 5 mM; Na 2 GTP, 0.3 mM; 300 mOsm/kg, adjusted to pH 7.2. The extracellular solution was composed of: NaCl, 140 mM; KCl, 5 mM; CaCl 2 , 3 mM; MgCl 2 , 6 mM; glucose, 5 mM; HEPES, 10 mM; bicuculline methchloride, 0.01 mM, and was adjusted to pH 7.4 with NaOH and to 315 mOsm/kg with sucrose. EPSCs were evoked with an extracellular bipolar concentric electrode placed next to the cell body of the presynaptic cell. The high [Mg ϩϩ ] o reduced polysynaptic responses and isolated the non-N-methyl-D]-aspartate (NMDA) component of the synaptic response.
Kainate and NMDA-gated currents were recorded from cells held at Ϫ70 mV and elicited by a 15 sec bath application of agonist (100 M) applied every 5 min. Kainate-evoked currents were recorded in the same solutions used to record EPSCs. For NMDA-evoked currents, the pipette was filled with CsMeSO 3 , 125 mM; CsCl, 15 mM; CaCl 2 ,3 mM; 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid, 11 mM; HEPES, 20 mM; MgATP, 5 mM; Na 2 GTP, 0.3 mM, pH 7.2 with CsOH, 300 mOsm/kg, and the external solution contained KCl, 5 mM; NaCl, 137 mM; CaCl 2 , 1.3 mM; HEPES, 20 mM; glucose, 5 mM; glycine, 10 M; strychnine, 2M; bicuculline methchloride, 10 M; CNQX, 10M; and tetradotoxin, 0.1M; pH 7.4 with NaOH, 315 mOsm/kg with sucrose. These currents were filtered at 20 Hz and sampled every 10 s. Displayed currents were not corrected for leak.
[Ca ϩϩ ] i was measured in single hippocampal neurons by indo-1-based microfluorimetry as described previously .
Experiments were performed at room temperature in a recording chamber (Thayer et al., 1988) that was continuously perfused with buffer composed of the following : HEPES, 20 mM; NaCl, 137 mM; CaCl 2 , 1.3 mM; MgCl 2 , 0.1 mM; KCl, 5.0 mM; KH 2 PO 4 , 0.4 mM; Na 2 HPO 4 , 0.6 mM; NaHCO 3 , 3.0 mM; glucose, 5.6 mM; and glycine, 0.01 mM; pH 7.45.
Data are presented as mean Ϯ S.E.M. Statistical comparisons were made by Student's t test and analysis of variance (ANOVA) with Bonferoni's post-test.
Results
Reducing . In this study, we used this method to study the effects of ⌬ 9 -THC on excitatory neurotransmission. As shown in Fig. 1A (Fig. 1B) . A complete concentration-response curve was generated for ⌬ 9 -THC-induced inhibition of [Ca ϩϩ ] i spiking activity. These data are plotted with data from the full agonist Win55212-2 in Fig. 4C . The slope factors, which in these experiments are equivalent to the Hill coefficients, were 1.3 Ϯ 0.2 and 1.6 Ϯ 0.3 for ⌬ 9 -THC and Win55212-2, respectively, suggesting that ⌬ 9 -THC activates a single class of noninteracting binding sites (De Lean et al., 1978) 
] i spiking with an EC 50 of 2.7 Ϯ 0.3 nM. The EC 50 for ⌬ 9 -THC was 20 Ϯ 4 nM and the maximal inhibition was 41 Ϯ 3%, indicating that in this system ⌬ 9 -THC exhibited high potency, but rather modest efficacy.
The psychotropic effects of ⌬ 9 -THC are mediated by CB1 cannabinoid receptors (Matsuda et al., 1990) . We used the selective CB1 receptor antagonist, SR141716, to determine whether the inhibitory effect of ⌬ 9 -THC on excitatory neurotransmission in hippocampal cultures was mediated by this receptor. As shown in Fig. 2A , 5 min pretreatment with 300 nM SR141716 completely prevented the effects of subsequent application of 100 nM ⌬ 9 -THC. In the absence of antagonist, 100 nM ⌬ 9 -THC inhibited the [Ca ϩϩ ] i spiking frequency by 40 Ϯ 5% (n ϭ 4) (Fig. 1A) . SR141716 alone did not significantly alter the basal spiking frequency (Fig. 2B) . The high superfusion rate used in these experiments precludes drawing conclusions regarding inhibitory tone mediated by endogenous cannabinoid receptor agonists.
The modest efficacy of ⌬ 9 -THC displayed in the concentration response curve suggested that this drug may act as a partial agonist on CB1 receptors to inhibit glutamatergic synaptic transmission. We tested this hypothesis by evaluat- (Fig. 3B) ] o results from the complex activity of a network of hippocampal neurons. In order to study glutamatergic synaptic activity in a more simple system, we recorded EPSCs by the whole-cell configuration of the patch-clamp technique. Synaptic currents were evoked by an extracellular concentric bipolar electrode placed near the soma of the presynaptic cell. The postsynaptic cell was voltage-clamped at Ϫ70 mV. To reduce polysynaptic responses, [Mg ϩϩ ] o was increased to 6 mM. That, together with the omission of glycine from the media, also blocked NMDA-receptor-mediated currents. Thus, evoked EPSCs were completely blocked by CNQX (Fig. 4A ) (n ϭ 10). ⌬ 9 -THC (100 nM) reduced EPSC amplitude by 57 Ϯ 4% (n ϭ 7; Fig. 1 ϭ 20 Ϯ 4 nM and 2.7 Ϯ 0.3 nM, respectively). Win55212-2 data were replotted from our previous study (Fig. 4 of for the purposes of comparison. Data points represent three to six experiments such as those shown in A and B, and are expressed as mean Ϯ S.E.M. Curves were fit by a logistic equation of the form percent Inhibition ϭ (I max )/(1ϩ (X/EC 50 ) b ), where X is the drug concentration, Im ax is the percent Inhibition calculated for an "infinite" concentration, and b is a slope factor that determines the steepness of the curve. EC 50 values were calculated by a nonlinear, least-squares curve fitting algorithm with Origin software (Microcal, Northampton, MA), and are expressed as mean Ϯ S.E.M. I max and b for ⌬ 9 -THC were 41 Ϯ 3% and 1.3 Ϯ 0.2, respectively. I max and b for Win55212-2 were 100% and 1.6 Ϯ 0.3, respectively. ] i spiking activity produced by this drug (Fig. 4A and C) . The full agonist Win55212-2 (100 nM) inhibited EPSC amplitude by 96 Ϯ 2% (n ϭ 8). ⌬ 9 -THC partially reversed the inhibition produced by the full agonist as shown in Fig. 4B . Combined application of Win55212-2 and ⌬ 9 -THC inhibited EPSC amplitude by 75 Ϯ 5% (n ϭ 6) (Fig. 4C) which was significantly different from that produced by Win55212-2 alone (p Ͻ .001).
We have shown previously that cannabimimetic drugs act presynaptically in this system to inhibit the release of glutamate . We explored the possibility that ⌬ 9 -THC might have additional postsynaptic effects by studying the effects of this drug on whole-cell currents evoked by the direct activation of nonNMDA and NMDA currents (Figs. 4D and E, respectively). Kainate elicited a large inward current that was not significantly (paired t test) affected by 100 nM ⌬ 9 -THC (1 Ϯ 2% inhibition; n ϭ 6). Kainate-evoked currents were blocked by 10 M CNQX (95 Ϯ 1% inhibition). NMDA also elicited large inward currents that were not significantly affected by 100 nM ⌬ 9 -THC (6 Ϯ 4% inhibition; n ϭ 4). NMDA-evoked currents were blocked by 10 M CGS19755 (85 Ϯ 3% inhibition). These data are consistent with the idea that ⌬ 9 -THC acts presynaptically to inhibit excitatory neurotransmission. (Tsou et al., 1998) and appears to mediate most of the behavioral effects of the cannabinoids (Matsuda et al., 1990) . (Devane et al., 1988) and the submicromolar K i values for displacement from brain slices (Herkenham et al., 1990) . (Sim et al., 1996a) . Studies that used brain slice preparations tended to require higher concentrations of cannabimimetic drugs, possibly because of greater nonspecific binding of these lipophilic compounds to more intact preparations. We speculate that ⌬ 9 -THC acted presynaptically to inhibit the release of glutamate similar to other cannabimimetic drugs we have tested in this system . Glutamatergic synaptic transmission in the hippocampus is essential for spatial learning tasks and cannabimimetic drugs have been shown to produce short term memory deficits in spatial learning paradigms (Lichtman and Martin, 1996) , suggesting that the effects described here may account for some of the behavioral effects of ⌬ 9 -THC. ⌬ 9 -THC exerted its effects on excitatory neurotransmission by acting as a partial agonist. This observation is consistent with tests of ⌬ 9 -THC in behavioral paradigms (Compton et al., 1992) as well as cellular and molecular studies that have described partial agonists that act on cannabinoid receptors. Anandamide inhibition of Ca ϩϩ currents in N18 cells was of limited efficacy (Mackie et al., 1993) and CP55940 was found to inhibit Ca ϩϩ current as a partial agonist in sympathetic neurons expressing CB1 receptors (Pan et al., 1996) . In a previous report from our laboratory, we showed that the synthetic cannabinoid CP55940 acted as a partial agonist to inhibit glutamate release . Sim et al. (1996a) and Burkey et al. (1997b) have shown that ⌬ 9 -THC acts as a partial agonist to stimulate [ 35 S]GTP␥S binding. Comparison of the efficacy for inhibition of glutamatergic synaptic activity with the structure of four cannabimimetic drugs, ⌬ 9 -THC and CP55940 that acted as partial agonists and desacetyllevonantradol and Win55212-2 that acted as a full agonists, suggests that a free aliphatic side chain at position 3 on the phenolic ring and the absence of a secondary or tertiary amine in the structure may be common to cannabinoids with partial agonist properties. The relative efficacy of partial agonists is dependent on the stoichiometry of the components of the signal transduction pathway on which it acts (Weiss et al., 1996) . The heterogeneous distribution of tial agonist activity in our system, that produced a steady inhibition throughout the 2 h exposure .
Discussion
In summary, ⌬ 9 -THC acts on CB1 receptors to inhibit glutamate-mediated synaptic transmission between cultured rat hippocampal neurons. In this in vitro system, ⌬ 9 -THC was potent, but of modest efficacy, which may account for many of the behavioral effects of this drug.
